Updated:
TVM Capital
Helmut Schühsler leads TVM Capital, a Munich-origin life-sciences VC that has deployed $1.3B+ across 250+ biopharma and medtech companies since 1983.
TVM Capital
Founded in 1983 and led by Chairman and CEO Helmut Schühsler since 1986, TVM Capital operates as a transatlantic venture-capital firm with a specialized focus on life sciences. The firm was created as a subsidiary of German insurer TVM (Techno Venture Management) and later spun out as an independent manager. From its Munich headquarters, TVM Capital established an early pattern of cross-border healthcare investing that bridged European early-stage science with US commercialization pathways. TVM Capital's strategy concentrates on therapeutic biotech, medical devices, and health-tech platforms. Stage coverage spans company formation through growth equity, executed via dedicated fund strategies including the TVM Life Science Ventures series and the TVM Capital Healthcare platform, the latter based in Dubai and Cairo and focused on emerging markets. Historical portfolio names include BioNTech co-founder Uğur Şahin's prior ventures, Devicor Medical Products (acquired by Danaher), and Auris Medical. The firm invests primarily in Europe and North America through its Munich-based venture funds, while the healthcare affiliate deploys across the Middle East, North Africa, and South Asia (per the firm's official communications). Total capital raised exceeds $1.3B across more than ten funds since inception (public record). In May 2024, TVM Capital Healthcare announced a $50M partnership with the Saudi Arabian Investment Company to back domestic healthcare companies (per the firm, May 2024). The firm operates offices in Munich, Dubai, and Cairo. TVM Capital's Munich venture team and TVM Capital Healthcare's emerging-markets team function as distinct investment units under a shared brand and governance structure. The structural differentiator is TVM Capital's dual-theater operating model: a Munich-based venture team investing in European and North American biotech, running parallel to a Dubai- and Cairo-based emerging-market healthcare private-equity business. This architecture creates a rare blend of early-stage drug-development expertise and frontier-market operational healthcare exposure under one roof, with each unit drawing on a separate pool of institutional and development-finance limited partners.
General information
Firm type
Asset Manager
Year founded
1983
AUM
$500M–$1B (Altss estimate)
Location
Region
Europe
Country
Germany
City
Munich
Corporate office
Munich, Germany
Additional offices
Dubai, UAE · Cairo, Egypt
Principals
Helmut Schühsler
Chairman & CEO
Stefan Fischer
Managing Partner
Sector focus
Frequently asked questions
What is TVM Capital's primary investment focus?
TVM Capital invests in life sciences, spanning therapeutic biotech, medical devices, and healthcare services. The Munich-based venture funds target early-stage European and North American life-science companies, while TVM Capital Healthcare focuses on growth-equity and buyout opportunities in the Middle East, North Africa, and South Asia.
How are the Munich venture team and the Middle Eastern healthcare team related?
Both operate under the TVM Capital brand and share governance, but function as distinct investment units. The Munich team runs transatlantic venture strategies for biotech and medical devices, while the Dubai- and Cairo-based TVM Capital Healthcare team manages private-equity funds targeting emerging-market healthcare provider and services companies, drawing from separate limited partners (per the firm's official communications).
Does TVM Capital co-invest alongside external GPs?
TVM Capital typically leads or co-leads rounds in its venture strategy and acts as the sole financial sponsor or lead investor in its healthcare private-equity deals. The firm does not market a fund-of-funds or open co-investment club product.
Which geographical regions does TVM Capital cover?
Through its venture operations, TVM Capital invests in Europe and North America. Through the TVM Capital Healthcare platform, the firm has an active presence across the Gulf Cooperation Council countries, Egypt, and South Asia.
Who makes investment decisions at TVM Capital?
Helmut Schühsler serves as Chairman and CEO with ultimate investment authority across the firm. Stefan Fischer is Managing Partner for the venture capital business, while the healthcare private-equity unit is led by a separate investment committee in Dubai and Cairo.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: